INS and type 2 diabetes mellitus: In conclusion, the HbA1c level closer to 47.5 mmol/mol achieved mainly with insulin-sensitizing agents and lifestyle modification would be a safe glycemic goal for improving the outcome measures of DPN in patients with poorly controlled type 2 diabetes with mild to moderate neuropathy.